Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Sales | 8,921 | 8,106 | 10,120 | 8,013 | 9,411 |
| Gross Profit | 8,921 | 8,106 | 10,120 | 8,013 | 9,411 |
| Operating Expenses | 26,773 | 25,638 | 24,705 | 25,504 | 25,051 |
| Operating Income | -17,852 | -17,532 | -14,585 | -17,491 | -15,640 |
| Interest Expense | 83 | 81 | 2 | 1 | 2 |
| Other Income | 316 | 468 | 725 | 683 | 702 |
| Pre-tax Income | -17,619 | -17,145 | -13,862 | -16,809 | -14,940 |
| Net Income Continuous | -17,619 | -17,145 | -13,862 | -16,809 | -14,940 |
| Net Income | $-17,619 | $-17,145 | $-13,862 | $-16,809 | $-14,940 |
| EPS Basic Total Ops | -2.38 | -2.31 | -1.82 | -2.24 | -2.03 |
| EPS Basic Continuous Ops | -2.35 | -2.29 | -1.84 | -2.25 | -2.00 |
| EPS Diluted Total Ops | -2.38 | -2.31 | -1.82 | -2.24 | -2.03 |
| EPS Diluted Continuous Ops | -2.35 | -2.29 | -1.84 | -2.25 | -2.00 |
| EBITDA(a) | $-15,038 | $-14,697 | $-11,735 | $-14,796 | $-13,094 |